Mind-Altering Drugs News ArticlesExcerpts of key news articles on mind-altering drugs
Psychedelic medicine is having a moment. Just weeks after the U.S. Food and Drug Administration approved Johnson & Johnson’s ketamine-like nasal spray for depression, a group of European technology investors ... got together for the largest-ever private financing round for a psychedelic medicine biotech company, ATAI. Psychedelic medicine involves research and investigations into mind-altering substances to treat mental illnesses including addiction, depression and post-traumatic stress disorder. After recreational use of psychedelics became popular in the 1960s, the U.S. government classified most of them “drugs of abuse” with no real medical value. However, recent clinical studies show mounting evidence that some psychedelics can help patients with certain mental illnesses, either in combination with traditional therapies or in cases where nothing else has worked. Now health and technology investors are paying attention. German company ATAI Life Sciences announced on Tuesday that it has raised more than $40 million in new financing. The round valued the company at $240 million, according to a person familiar, making it both the biggest round and the most valuable company in the young space. ATAI is currently funding clinical trials for what it refers to as “formerly stigmatized compounds,” including psilocybin, the active compound in psychedelic mushrooms, and arketamine, a different variant of ketamine from the one Johnson & Johnson researched, as potential treatments for depression.
Note: Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.
CBD, the non-psychoactive compound found in cannabis, hemp and hops, has been getting a lot of attention from the media recently. On the other hand, THC, the psychoactive compound in cannabis that makes people feel “high” or “stoned,” is often overlooked (and sometimes even looked down on) when discussing marijuana’s medical potential. However, a new study ... published on the Scientific Reports journal on Tuesday, revealed that THC exhibited the “strongest correlation with therapeutic relief, compared to the more socially acceptable chemical found in cannabis, CBD (cannabinol).” Cannabinoid content, and especially THC content, came out as the main factor for optimizing symptom relief, when tested for a wide variety of health conditions. [Study co-author Jacob Miguel] Vigil explained the results derived from the observation of real-time data from Releaf App, which he qualified as “the largest database of its kind in our country.” Using the app, patients reported the results and effects of their actual cannabis use. The researchers discovered cannabis is more effective for the treatment of mental symptoms like agitation, irritability, anxiety, depression, excessive appetite, insomnia, loss of appetite, nausea, gastrointestinal pain, stress and tremors, than it is in the treatment of physical ailments. Despite the conventional wisdom ... that only CBD has medical benefits while THC merely makes one high, our results suggest that THC may be more important than CBD in generating therapeutic benefits.
MDMA, the principal ingredient in the party drug ecstasy, is about to give a lifeline to some of the worst sufferers of post-traumatic stress disorder (PTSD) in Israel. The U.S. could be just years behind in launching similar clinical treatments using the substance. Israel’s Ministry of Health has approved the use of MDMA, a psychoactive drug, for use on dozens of patients. While the drug is still on the country’s law books as dangerous for recreational use, it is now being administered as treatment for compassionate use. In compassionate cases the drug will be made available to patients outside of clinical trials if they have not responded sufficiently to other medications or treatments. MDMA makes people feel euphoric, a sensation that made its use synonymous with rave culture and EDM (Electronic Dance Music), because it floods the body with serotonin. Serotonin is produced by nerve cells. When levels are low it can lead to depression and disrupt other physiological processes. The launching of the new Israeli initiative is a direct result of groundbreaking research in the U.S. The Middle Eastern nation approved the program after sending a representative to the California-based Multidisciplinary Association for Psychedelic Studies (MAPS) for training. MDMA has been illegal in the U.S. since 1985 but the findings of clinical trials, ongoing with Food and Drug Administration (FDA) approval since 2001, have shown that the drug enhances the treatment of PTSD in a clinical setting.
Note: Read also a CBC article titled "How psychedelic drugs are changing lives and transforming psychiatry." For more along these lines, see concise summaries of deeply revealing mind altering drugs news articles from reliable major media sources.
It's the little things that Jon Lubecky appreciates now, like playing a board game with his family. But it wasn't always that way for the former Army sniper, who came home in 2006 after nearly a year in Iraq with a traumatic brain injury from a mortar attack and a nasty case of post-traumatic stress disorder (PTSD). Traditional treatments, including the use of antidepressants like Zoloft, were useless. Over three sessions, Lubecky spent six to eight hours under the influence of MDMA, the active ingredient in ecstasy. Finally, Lubecky was able to talk about his trauma and thus make progress dealing with it. Rick Doblin runs the Multidisciplinary Association for Psychedelic Studies, or MAPS, a non-profit advocating for MDMA-assisted psychotherapy. "It starts by reducing activity in the amygdala, which is the fear-processing part of the brain, so that people's fearful emotions linked to trauma can be more easily recalled and processed," Doblin said. Once the drug produces feelings of safety, veterans can then access memories which had been crippling before. While one in three veterans found pills like Zoloft and Paxil effective in treating their PTSD, a study including 24 veterans showed PTSD was eliminated in 68 percent of vets treated with MDMA-assisted therapy and significantly reduced in the other 32 percent. MDMA-assisted therapy is now about to begin its third phase of FDA testing. If all goes well, MDMA will be available by prescription as early as 2021.
Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs.
Recreational marijuana use will soon be legal in Canada after the Senate passed a "historic" bill. Canada is only the second country in the world - and the first G7 nation - to implement legislation to permit a nationwide marijuana market. In the neighboring US, nine states and the District of Columbia now allow for recreational marijuana use, and 30 allow for medical use. The Cannabis Act, stems from a campaign pledge of Prime Minister Justin Trudeau to keep marijuana away from underage users and reduce related crime. Uruguay was the first country to legalize marijuana's production, sale and consumption in December 2013. The justice minister, Jody Wilson-Raybould, ... applauded the vote. "This is an historic milestone for progressive policy in Canada," she tweeted. "This legislation will help protect our youth from the risks of cannabis while keeping profits out of the hands of criminals and organized crime." Once the bill is formally approved, adults will be able to carry and share up to 30 grams of legal marijuana in public. They also will be allowed to cultivate up to four plants in their households. However, stringent rules will still govern the purchase and use of marijuana. Consumers are expected to purchase marijuana from [regulated] retailers. Marijuana will also not be sold in the same location as alcohol or tobacco. The Canadian government has also implemented changes to their impaired driving laws, to address repercussions for driving under the influence of cannabis.
Note: In the US, more people are arrested for marijuana use than for all violent crimes combined.
It was only after U.S. veteran Jonathan Lubecky pulled the trigger on a loaded gun aimed at his head and it misfired that he finally decided to seek help. He had tried to commit suicide five times after struggling with post-traumatic stress disorder (PTSD). The only two drugs approved by the Food and Drug Administration for PTSD, Zoloft and Paxil ... didn’t work for combat-related PTSD. Out of desperation, he volunteered as a subject in an experimental study of MDMA-assisted psychotherapy for chronic, treatment-resistant PTSD. The study was sponsored by the ... Multidisciplinary Association for Psychedelic Studies (MAPS), and funded entirely by private donations. After his treatment with MDMA-assisted psychotherapy, Lubecky managed to heal from his PTSD to the point that he became National Veterans Director for Senator Rand Paul’s 2016 presidential primary campaign. His recovery is not unusual. The Lancet Psychiatry published a scientific paper about the study Lubecky volunteered for; it reported that two-thirds of the 26 veterans, firefighters and police officers treated no longer qualified for a diagnosis of PTSD one month after their second MDMA session, with their reduction of PTSD symptoms lasting over time. Drug prohibition has for decades delayed medical research into the healing properties of Schedule 1 drugs. Now that this research is finally being conducted, we’re learning that enormous suffering and many suicides could have been prevented over these decades.
Note: The above was written by MAPS founder Rick Doblin. Read more about how MDMA, also known as 'ecstasy,' has been found to be effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.
In recent years, rigorous research has been conducted on entheogens, such as ayahuasca, LSD, mescaline and psilocybin, and on the empathogen Ecstasy. The goal is to evaluate their effects on addiction, cluster headaches, depression, trauma, cancer, epilepsy, death and dying, as well as to explore their value in the study of consciousness. Psilocybin - or magic mushrooms - have been used in traditional healing rituals for thousands of years. However, for more than 40 years it has been illegal in the U.S. But recent findings are tearing down the barriers surrounding psychedelic research, as it has been clinically shown that they have the ability to ease depression and soothe anxiety in patients dealing with serious illness and impending death. Two separate studies discovered that a single, moderate-to-large dose of psilocybin was able to help alleviate profound distress among cancer patients. Researchers know “how,” but they do not know “why,” psilocybin has worked in these settings. One theory is that psilocybin interrupts the circuitry of self-absorbed thinking that is so pronounced in depressed people, making way for a mystical experience. Neuro-imaging studies ... suggest that the positive effects of psychedelic-assisted psychotherapy are explained by changes in something in the brain called “the default mode network.” It turns out that this network is hyperactive in depression. Interestingly, in both meditation and also with psilocybin this network becomes quiescent.
Note: See an article in the UK's Independent showing remarkable results from these studies. Learn more about the healing potentials of mind-altering drugs now being explored by the scientific community.
After months of deliberation and investigation, the WHO has concluded that cannabidiol (CBD) is a useful treatment for epilepsy and palliative care, and does not carry any addiction risks. The organization is set to run a fuller review of cannabis next year. The report ... also recommended imposing the strong restrictions available on fentanyl, a synthetic opioid which has killed thousands of people in America’s drug addiction epidemic. “There is increased interest from Member States in the use of cannabis for medical indications including for palliative care,” the report said. “Responding to that interest and increase in use, WHO has in recent years gathered more robust scientific evidence on therapeutic use and side effects of cannabis and cannabis components.” In conclusion, the authors wrote: “Recent evidence from animal and human studies shows that its use could have some therapeutic value for seizures due to epilepsy and related conditions.” They added that ‘current information does not justify scheduling of cannabidiol’, and declared that taking medical marijuana will not lead to addiction to THC, the psychoactive property of cannabis that induces a ‘high’.
Note: More people are arrested in the US for marijuana use than for all violent crimes combined and the US federal government continues to regard non-psychoactive CBD as a dangerous drug. The UK government recently announced it will regulate CBD as medicine. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.
Against the backdrop of the nation's largest Veterans Day parade, Democratic Gov. Andrew Cuomo announced this month he'd sign legislation making New York the latest in a fast-rising tide of states to OK therapeutic pot as a PTSD treatment, though it's illegal under federal law. Twenty-eight states plus the District of Columbia now include PTSD in their medical marijuana programs, a tally that has more than doubled in the last two years. The increase has come amid increasingly visible advocacy from veterans' groups. Retired Marine staff sergeant Mark DiPasquale says the drug freed him from the 17 opioids, anti-anxiety pills and other medications that were prescribed to him for migraines, post-traumatic stress and other injuries from service that included a hard helicopter landing in Iraq in 2005. In a sign of how much the issue has taken hold among veterans, the 2.2-million-member American Legion began pressing the federal government this summer to let Department of Veterans Affairs doctors recommend medical marijuana where it's legal. The Legion started advocating last year for easing federal constraints on medical pot research, a departure into drug policy for the nearly century-old organization. "People ask, `Aren't you the law-and-order group?' Why, yes, we are," Executive Director Verna Jones said at a Legion-arranged news conference early this month at the U.S. Capitol. But "when veterans come to us and say a particular treatment is working for them, we owe it to them to listen and to do scientific research required."
Note: This Associated Press article no longer appears on CNBC's website. Here's an alternate link for the complete article. The illegal drug MDMA was recently fast tracked for FDA approval after preliminary studies found it to be effective for treating PTSD in a therapeutic context. While police in the US arrest more people for marijuana use than for all violent crimes combined, articles like these suggest that the healing potentials of mind-altering drugs are gaining mainstream credibility.
Scientists at Johns Hopkins University in Baltimore have enlisted two dozen religious leaders from a wide range of denominations, to participate in a study in which they will be given two powerful doses of psilocybin, the active ingredient in magic mushrooms. Dr William Richards ... who is involved in the work, said: “With psilocybin these profound mystical experiences are quite common. It seemed like a no-brainer that they might be of interest, if not valuable, to clergy.” The experiment, which is currently under way, aims to assess whether a transcendental experience makes the leaders more effective and confident in their work and how it alters their religious thinking. Despite most organised religions frowning on the use of illicit substances, Catholic, Orthodox and Presbyterian priests, a Zen Buddhist and several rabbis were recruited. The team has yet to persuade a Muslim imam or Hindu priest to take part, but “just about all the other bases are covered,” according to Richards. The participants have been given two powerful doses of psilocybin in two sessions, one month apart. “Their instruction is to go within and collect experiences,” Richards said. “So far everyone incredibly values their experience. No one has been confused or upset or regrets doing it.” A full analysis of the outcomes will take place after a one-year follow-up with the participants, whose identities are being kept anonymous. “It is too early to talk about results, but generally people seem to be getting a deeper appreciation of their own religious heritage,” he said.
Note: In 1962, a similar experiment was conducted called the "Good Friday Experiment." Almost all of the members of the experimental group reported experiencing profound religious experiences. In 2002, a similar experiment at Johns Hopkins University yielded similar results. Learn about both of these in this Wikipedia article. Read more about the potentials of mind altering drugs now being explored by the scientific community.
For as long as Alice, now 32, can remember, her father, “a major drug dealer with freezers full of cocaine”, was physically abusive towards her and her mother. Alice’s post-traumatic stress disorder (PTSD) ... went misdiagnosed for many years. She tried [many therapies]. Nothing worked. Then, two and a half years ago, Alice enrolled in a clinical trial for a treatment combining psychotherapy with MDMA. Her “trips” were accompanied by eight-hour therapy sessions. During the session[s], her psychiatrist guided the conversation according to goals she had set with Alice beforehand. Alice’s recovery was astonishing. The clinician-administered PTSD scale, or Caps ... uses a lengthy questionnaire to determine the severity of a patient’s symptoms. Any score over 60 is “severe”. Alice’s score went from 106 to two. It’s now at zero. In other words, her PTSD is gone. Alice is one of 136 patients who have undergone MDMA-assisted psychotherapy in trials run by the not-for-profit Multidisciplinary Association for Psychedelic Studies (Maps), based in Santa Cruz, California. [In] one South Carolina study ... 83% of those given the MDMA no longer met the criteria for PTSD following treatment, compared with 25% of those who were not given the drug. Best of all? The results have held for several years. MDMA is not a silver bullet: treatment is heavily reliant on the accompanying therapy, and there is a lot of therapy: three monthly sessions with the drug, lasting eight hours each, punctuated by nine weekly 90-minute sessions without it.
Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are beginning to gain mainstream scientific credibility.
The German writer Norman Ohler['s] book ... "The Total Rush" – or, to use its superior English title, "Blitzed" – reveals the astonishing and hitherto largely untold story of the Third Reich’s relationship with drugs, including cocaine, heroin, morphine and, above all, methamphetamines (aka crystal meth). The story Ohler tells begins in the days of the Weimar Republic, when ... Hitler’s inner circle established an image of him as an unassailable figure who was willing to work tirelessly on behalf of his country, and who would permit no toxins – not even coffee – to enter his body. When the Nazis seized power in 1933, “seductive poisons” were immediately outlawed. Some drugs, however, had their uses. A substance that could “integrate shirkers, malingerers, defeatists and whiners” into the labour market might even be sanctioned. Ohler describes [the methyl-amphetamine Pervitin] as National Socialism in pill form. In 1940, as plans were made to invade France through the Ardennes mountains, a “stimulant decree” was sent out to army doctors, recommending that soldiers take [Pervitin]. The invasion of France was made possible by the drugs. In Berlin, Hitler was [prescribed injections of] a designer opiate. He would combine it with twice daily doses of the high grade cocaine. The effect of the drugs could appear to onlookers to be little short of miraculous. One minute the Führer was so frail he could barely stand up. The next, he would be ranting unstoppably at Mussolini.
Don Winslow['s book] The Cartel, a sequel to 2005's The Power of the Dog [is] a sort of Game of Thrones of the Mexican drug wars, a multipart, intricately plotted, blood-soaked epic that tells the story of how America's unquenchable appetite for illegal drugs has brought chaos to our southern neighbors and darkened our own political and criminal culture. Dog ... traces the rise of the narcotraficantes who split Mexico into territories and smuggled cocaine across the U.S. border by the ton. The violence ... spills out into Mexican society, turning cities like Juarez into Fallujah-like battle zones. But the most shocking thing about these books is that almost all the horror stories Winslow tells ... are largely true – from the narcotrafficker who threw children off a bridge to ... countless murders, kidnappings and tortures. The War on Drugs is a trillion-dollar failure. We spend billions of dollars pursuing drugs and billions imprisoning people that probably shouldn't be in prison. This war has killed a hundred thousand people in Mexico. These ISIS beheadings that we're seeing [are] a direct copy of what the cartels were doing in 2007 and 2008. The Zetas had imported Special Forces veterans from the Guatemalan army – and one of their things was to cut off heads. [There's] a direct line between events in Ferguson and Baltimore and Cleveland to the War on Drugs. The fruits that we're reaping now are seeds that were planted back in 1971, when Nixon declared war on drugs. The War on Drugs is more of a problem to the United States than drugs are.
Note: For more along these lines, see concise summaries of deeply revealing news articles on drugs from reliable major media sources on little-known facts about mind-altering drugs. Then explore the excellent, reliable resources provided in our War Information Center.
A group of British scientists started a crowdfunding campaign to raise the remaining 25,000 pounds (about $37,600) needed to complete the first scientific study ever to image the brains of people "tripping" on the psychedelic drug LSD. Led by neuroscientists at Imperial College London, the study seeks to use MRI and MEG imaging to show how LSD affects brain processes. It is part of a research project that the scientists say could revolutionize the understanding of the human brain. Researchers hope the images will begin to reveal the way the drug could work to heal many debilitating conditions such as obsessive compulsive disorder, alcohol addiction, depression and anxiety. The public's response to the crowdfunding appeal was overwhelming. Within the first 24 hours after its request was posted online, the Beckley Foundation/Imperial College [exceeded] its goal. "We went into it tenuously and have been delighted by the response," said [Beckley Foundation Psychedelic Research Foundation director Amanda] Fielding. "It's an incredibly important area. LSD is something that can expand certain areas of the human personality: openness, spirituality, and creativity. Fielding's team is working hard to provide substantial scientific research to help eliminate the taboo of LSD and other hallucinogenic substances and loosen regulations on scientific testing. "There are many millions of people who have experienced the benefits of psychedelics, and there are millions of people who are suffering with illnesses that want to see if these drugs can help," said Fielding.
Note: It took just 24 hours for the public to fund this study directly. Are the healing potentials of mind altering drugs finally starting to receive honest mainstream attention?
It is now one hundred years since drugs were first banned. Through this long century of waging war on drugs, we have been told a story about addiction by our teachers and by our governments. Almost everything we have been told about addiction is wrong. Nearly fifteen years ago, Portugal had one of the worst drug problems in Europe, with 1 percent of the population addicted to heroin. They had tried a drug war, and the problem just kept getting worse. So they decided to do something radically different. They resolved to decriminalize all drugs, and transfer all the money they used to spend on arresting and jailing drug addicts, and spend it instead on reconnecting them - to their own feelings, and to the wider society ... so they have a purpose in life, and something to get out of bed for. They are helped, in warm and welcoming clinics, to learn how to reconnect with their feelings, after years of trauma and stunning them into silence with drugs. The results of all this are now in. An independent study by the British Journal of Criminology found that since total decriminalization, addiction has fallen, and injecting drug use is down by 50 percent. For too long, we have talked exclusively about individual recovery from addiction. We need now to talk about social recovery - how we all recover, together, from the sickness of isolation. But this new evidence isn't just a challenge to us politically. It doesn't just force us to change our minds. It forces us to change our hearts.
Note: The above was written by Johann Hari, bestselling author of Chasing The Scream: The First and Last Days of the War on Drugs. Read more about Portugal's stunning success in curbing drug addiction by ending its drug war and cultivating human connection. For more, read about how the science behind the bonding theory of addiction has been suppressed since the 1970's by drug war profiteers.
Tucked deep inside the 1,603-page federal spending measure is a provision that effectively ends the federal government's prohibition on medical marijuana and signals a major shift in drug policy. The bill's passage ... marks the first time Congress has approved nationally significant legislation backed by legalization advocates. It brings almost to a close two decades of tension between the states and Washington over medical use of marijuana. Under the provision, states where medical pot is legal would no longer need to worry about federal drug agents raiding retail operations. Agents would be prohibited from doing so. Congress for years had resisted calls to allow states to chart their own path on pot. The marijuana measure, which forbids the federal government from using any of its resources to impede state medical marijuana laws, was previously rejected half a dozen times. Even as Congress has shifted ground on medical marijuana, lawmakers remain uneasy about full legalization. Marijuana proponents nonetheless said they felt more confident than ever that Congress was drifting toward their point of view. Approval of the pot measure comes after the Obama administration directed federal prosecutors last year to stop enforcing drug laws that contradict state marijuana policies.
Psychedelics, the drugs of choice for many in the 1960s counterculture movement, may be making a comeback. Scientists, doctors and scholars who have researched the health potential of drugs such as LSD, magic mushrooms and ecstasy, gathered at the Horizons conference ... to discuss innovations in the field. Psychedelics ... went out of favor with the law in the 1960s and 1970s, [which] slammed the lid on research. Those prohibitions seem to be loosening somewhat, with some governments allowing a small amount of research with psychedelic drugs, results of which show they may carry promise for treating a wide variety of ailments, from anxiety to addiction. “Some of the most significant civilizations have given an honored place to psychedelics,” scholar and writer Graham Hancock told conference attendees. Hancock said hallucinogenic mushrooms played a part in cultures such as the Mayan Civilization and were depicted in European and African cave paintings as far back as 9,000 years ago. A recently completed project at New York University found that psilocybin appears to reduce anxiety and depression in terminal cancer patients. It appeared that psilocybin led many of the study participants, who were all in various stages of life-threatening cancer, to have “mystical experiences” that gave them great insights, improved their anxiety and generally made them more positive and loving, they and their loved ones reported. To date there have been no adverse reactions to psilocybin in any study.
Dr Sanjay Gupta: There's a group of outlawed drugs out there that are generating new interest among a growing number of doctors. Some of these drugs include things like MDMA also known as ecstasy, also LSD. Psychiatrists have (long) been fascinated by the properties of psychedelics. The U.S. military's efforts in the 1950s ... tested LSD as a potential weapon. But the interests in these drugs didn't stay in the lab. They trickled on to the black market and were soon outlawed. The pattern repeated itself with MDMA. Therapists tried it with patients. Millions tried it on their own. And in 1985, it was banned under federal law. Over the last decade, a small band of researchers wrangled permission to try again. This time giving MDMA during therapy sessions with patients who were suffering post-traumatic stress. DR. MICHAEL MITHOEFER, TESTING MDMA AS TREATMENT FOR PTSD PATIENTS: It was revisiting the trauma that was painful. The MDMA seemed to make it possible for them to do it effectively. GUPTA: Dr. Mithoefer has treated nearly 50 patients. He's currently working with veterans. RICK DOBLIN, MULTIDISCIPLINARY ASSOCIATION FOR PSYCHEDELIC STUDIES: People are able to look at traumatic memories, the fear is reduced, and then they're able to separate out it was happening then and not now. GUPTA: So, if they're going through counselling, for example, it could make that counselling more effective, they're not as paralyzed if you will by the memories that are being brought up? DOBLIN: We're saying that MDMA itself is not the medicine, it's MDMA assisted psychotherapy.
Note: Watch this CNN news clip and decide for yourself. For more about how the CIA secretly experimented on people with LSD and other drugs, read this deeply revealing information about a project called MK ULTRA. For more about the legitimate therapeutic uses of these drugs, and how investigation into these is suppressed, see these concise summaries of deeply revealing news articles from reliable sources.
Researchers aren't sure why, but in the 23 U.S. states where medical marijuana has been legalized, deaths from opioid overdoses have decreased by almost 25 percent, according to a new analysis. "Most of the discussion on medical marijuana has been about its effect on individuals in terms of reducing pain or other symptoms," said lead author Dr. Marcus Bachhuber. "The unique contribution of our study is the finding that medical marijuana laws and policies may have a broader impact on public health." California, Oregon and Washington first legalized medical marijuana before 1999, with 10 more following suit between then and 2010, the time period of the analysis. Another 10 states and Washington, D.C. adopted similar laws since 2010. For the study, Bachhuber, of the Philadelphia Veterans Affairs Medical Center and the University of Pennsylvania, and his colleagues used state-level death certificate data for all 50 states between 1999 and 2010. In states with a medical marijuana law, overdose deaths from opioids like morphine, oxycodone and heroin decreased by an average of 20 percent after one year, 25 percent by two years and up to 33 percent by years five and six compared to what would have been expected, according to results in JAMA Internal Medicine. Meanwhile, opioid overdose deaths across the country increased dramatically, from 4,030 in 1999 to 16,651 in 2010, according to the Centers for Disease Control and Prevention (CDC). Three of every four of those deaths involved prescription pain medications.
Note: For more on this, see concise summaries of deeply revealing mind-altering drug news articles from reliable major media sources.
Buried in February’s $956 billion farm bill is an amendment ... that legally distinguishes industrial hemp from marijuana, after decades of conflation [of the two]. It defines hemp as an agricultural crop rather than a drug — and effectively frees American farmers to grow it for the first time in almost 60 years. For 20 years, legislators, farmers, hippies, activists, agency heads and agronomists have worked to recast hemp as a game-changer, an American cash crop that could jump-start the country's next economic revival. Colorado, Vermont and Kentucky wasted no time launching their industrial hemp research and the pilot programs provided for in the farm bill. In an obscure notice dated April 16th, the USDA alerted state and county officials that farmers in states that [approved] hemp production (15 so far) could now include hemp acreage in their crop reports. The floodgates have opened. The current American hemp market is estimated at nearly half a billion dollars, with hemp’s oil, seed and fiber used in food, carbon-negative building materials, and automobile composites that are already inside millions of cars. Hemp cultivation is ... as old as the country itself. George Washington and Thomas Jefferson grew it, hemp was once legal tender, and several drafts of the Declaration of Independence were written on hemp paper. During WWII, American farmers were paid to grow it, cultivating more than 150 million pounds of industrial hemp to support the American war effort.
Note: Hemp is derived from the cannabis sativa plant, which also produces marijuana. For news on mind altering substances, see the deeply revealing reports from reliable major media sources available here.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.